Ginkgo Biloba, often referred to simply as ginkgo, is one of the oldest living tree species on Earth, with a history that stretches back over 200 million years. This ancient tree is native to China and has been used in traditional medicine for thousands of years. Its fan-shaped leaves are unique and easily recognizable, and they are the primary source of the extracts used in modern supplements.

The Ginkgo Biloba tree is renowned for its resilience and longevity; individual trees can live for more than a thousand years. The leaves of the tree contain several bioactive compounds, such as flavonoids and terpenoids, which are believed to contribute to its therapeutic properties. These compounds are known for their antioxidant effects, which help protect cells from damage by free radicals.

In traditional Chinese medicine, Ginkgo Biloba has been used to support respiratory health, improve circulation, and enhance cognitive function. Today, it is primarily marketed as a dietary supplement aimed at improving memory, cognitive function, and circulation. The most commonly used form in supplements is the standardized extract, often referred to as EGb 761, which is derived from the leaves of the tree and contains a specific concentration of the active compounds.

Ginkgo Biloba is primarily used to enhance cognitive function, improve memory, and support overall brain health. It is also utilized for its potential benefits in treating various conditions such as intermittent claudication, tinnitus, and vertigo. Additionally, Ginkgo Biloba is sometimes recommended for alleviating symptoms associated with premenstrual syndrome (PMS) and vitiligo.

Several studies have explored the efficacy of Ginkgo Biloba in various applications. For cognitive function and memory enhancement, some research has shown promising results. A review published in the Journal of Alzheimer's Disease indicated that Ginkgo Biloba might improve cognitive function in individuals with mild cognitive impairment or Alzheimer's disease, although the findings were not universally consistent (Tan et al., 2014). Another meta-analysis found that Ginkgo Biloba could help stabilize or slow the decline in cognition, function, and behavior in dementia patients, particularly those with neuropsychiatric symptoms (Tan et al., 2015).

In the context of circulatory disorders like intermittent claudication, Ginkgo Biloba has demonstrated some potential benefits. A meta-analysis published in The American Journal of Medicine found that Ginkgo Biloba extract was superior to a placebo in improving pain-free walking distance in patients with this condition, although the overall effect size was modest (Pittler & Ernst, 2000).

For conditions like tinnitus and vertigo, the evidence is mixed. Some studies suggest a potential benefit, while others do not find significant improvements. For example, a study published in the International Journal of Audiology found that Ginkgo Biloba could improve symptoms in some patients with tinnitus, but the results were not conclusive across all studies reviewed.

Regarding PMS, a study published in the Journal of Alternative and Complementary Medicine reported that Ginkgo Biloba significantly reduced the severity of PMS symptoms compared to a placebo, particularly in terms of physical and psychological symptoms (Ozgoli et al., 2009). Similarly, in the treatment of vitiligo, Ginkgo Biloba has shown potential benefits. A study published in Clinical and Experimental Dermatology indicated that Ginkgo Biloba extract could help arrest the progression of vitiligo and promote repigmentation of the skin (Parsad et al., 2003).

Overall, while Ginkgo Biloba shows promise in various therapeutic applications, the results of studies are sometimes inconsistent, and further research is needed to fully understand its efficacy and mechanisms of action across different conditions.

Ginkgo Biloba works through several mechanisms, primarily driven by its rich composition of bioactive compounds, including flavonoids, terpenoids, and organic acids. These compounds contribute to its antioxidant, anti-inflammatory, and vasodilatory properties, which collectively support its therapeutic effects on cognitive function, circulatory health, and other conditions.

One of the primary mechanisms by which Ginkgo Biloba exerts its effects is through its antioxidant activity. The flavonoids and terpenoids in Ginkgo Biloba, such as quercetin, kaempferol, bilobalide, and ginkgolides, help neutralize free radicals and reduce oxidative stress. Oxidative stress is a key factor in the aging process and the development of various neurodegenerative diseases, including Alzheimer's disease. By scavenging free radicals, Ginkgo Biloba helps protect cells, particularly neurons, from damage, thereby supporting cognitive health and function (Ahlemeyer & Krieglstein, 2003).

Another significant mechanism is its ability to improve blood flow and circulation. Ginkgo Biloba enhances endothelium-dependent vasodilation, which increases blood flow to various tissues, including the brain. This is facilitated by the modulation of nitric oxide (NO) levels, which play a crucial role in vasodilation. Studies have shown that Ginkgo Biloba can improve coronary and cerebral blood flow, which may help alleviate symptoms of conditions like intermittent claudication and cognitive decline (Wu et al., 2008; Mashayekh et al., 2011).

Ginkgo Biloba also exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines and enzymes such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). These anti-inflammatory effects can help reduce neuronal inflammation, which is implicated in neurodegenerative diseases and other inflammatory conditions (Cheung et al., 1999).

Additionally, Ginkgo Biloba has been found to modulate neurotransmitter systems, particularly those involving acetylcholine, dopamine, and serotonin. These neurotransmitters are critical for memory, mood, and cognitive function. By influencing these neurotransmitter systems, Ginkgo Biloba may help improve cognitive performance and mood (Yoshitake et al., 2010).

In summary, Ginkgo Biloba works through a combination of antioxidant, vasodilatory, anti-inflammatory, and neurotransmitter-modulating mechanisms. These multifaceted actions contribute to its potential benefits in improving cognitive function, enhancing circulation, and alleviating symptoms of various conditions.

Ginkgo Biloba is utilized in both men’s and women’s health, but the specific applications and benefits can vary based on gender-specific health issues. While the core benefits of Ginkgo Biloba—such as improved cognitive function, enhanced circulation, and antioxidant properties—are relevant to both genders, some studies highlight unique advantages for men and women.

In men’s health, Ginkgo Biloba is often examined for its potential benefits in sexual health and cognitive performance. Some research suggests that Ginkgo Biloba may improve erectile function due to its vasodilatory effects, which can enhance blood flow to the genital area. This makes it a potential natural remedy for erectile dysfunction (ED). A study published in the Journal of Sex & Marital Therapy indicated that Ginkgo Biloba might improve sexual function in men experiencing ED, particularly when the condition is related to antidepressant use (Cohen & Bartlik, 1998). Additionally, Ginkgo Biloba is frequently used by men to support cognitive function, reduce symptoms of anxiety, and improve overall mental clarity, particularly as they age.

For women, Ginkgo Biloba is often used to alleviate symptoms associated with hormonal changes and menstrual cycles. One notable application is in the management of premenstrual syndrome (PMS). A study published in the Journal of Alternative and Complementary Medicine found that Ginkgo Biloba significantly reduced the severity of PMS symptoms, including both physical and psychological symptoms (Ozgoli et al., 2009). This makes Ginkgo Biloba a popular supplement among women seeking natural relief from PMS.

Furthermore, Ginkgo Biloba may play a role in managing menopausal symptoms. Some women use Ginkgo Biloba to help mitigate cognitive decline and mood swings associated with menopause. The antioxidant and neuroprotective properties of Ginkgo Biloba can support mental clarity and reduce oxidative stress, which may be beneficial during the menopausal transition.

In both men and women, Ginkgo Biloba is explored for its potential to improve cognitive function and reduce the risk of neurodegenerative diseases such as Alzheimer's. However, the specific hormonal and physiological differences between genders can influence the efficacy and usage patterns of Ginkgo Biloba supplements.

Overall, while the fundamental benefits of Ginkgo Biloba are applicable to both men and women, its use in addressing gender-specific health concerns such as erectile dysfunction in men and PMS or menopausal symptoms in women highlights its versatility as a supplement.

The appropriate dosage of Ginkgo Biloba can vary depending on the condition being treated and the specific formulation of the supplement. Generally, dosages range from 120 mg to 240 mg per day, divided into two or three doses. It's important to follow the recommended dosage on the product label or as advised by a healthcare professional.

For cognitive enhancement and overall brain health, a common dosage is 120 mg to 240 mg per day, divided into two or three doses. Studies have shown that this dosage range can help improve cognitive function, memory, and attention in both healthy individuals and those with cognitive impairments. For instance, a study published in the Journal of Alzheimer's Disease found that a dosage of 240 mg per day of Ginkgo Biloba extract (EGb 761) was effective in stabilizing cognitive function in patients with mild cognitive impairment (Tan et al., 2015).

When using Ginkgo Biloba for circulatory issues such as intermittent claudication, the recommended dosage typically falls within the same range of 120 mg to 240 mg per day. A meta-analysis published in The American Journal of Medicine recommended a dosage of 120 mg to 240 mg per day to improve pain-free walking distance in patients with this condition (Pittler & Ernst, 2000).

For managing symptoms of premenstrual syndrome (PMS), a study published in the Journal of Alternative and Complementary Medicine used a dosage of 40 mg three times daily (120 mg per day) to achieve significant reductions in PMS symptoms (Ozgoli et al., 2009).

In the context of vitiligo, a study published in Clinical and Experimental Dermatology reported that a dosage of 40 mg three times daily (120 mg per day) helped arrest the progression of the disease and promoted repigmentation of the skin (Parsad et al., 2003).

It's crucial to start with the lowest effective dose and gradually increase if necessary, under the guidance of a healthcare provider. Additionally, because Ginkgo Biloba can interact with certain medications and health conditions, it's important to consult a healthcare professional before starting supplementation, especially if you are taking other medications or have underlying health issues.

In summary, while the typical dosage of Ginkgo Biloba ranges from 120 mg to 240 mg per day, the exact amount may depend on the specific health condition being addressed. Always follow the recommended dosage on the product label or consult with a healthcare provider to determine the most appropriate dosage for your individual needs.

Ginkgo Biloba is generally considered safe for most people when taken at recommended dosages. However, like any supplement, it can cause side effects in some individuals. The most commonly reported side effects are mild and include gastrointestinal upset, headache, dizziness, and allergic skin reactions. These effects are usually transient and tend to resolve as the body adjusts to the supplement.

Gastrointestinal issues such as nausea, diarrhea, and stomach cramps are among the most frequently reported side effects. These symptoms can occur when Ginkgo Biloba is taken on an empty stomach, so it is often recommended to take the supplement with food to minimize these effects.

Headaches and dizziness can also occur, particularly when starting the supplement or when taking higher doses. If these symptoms persist or become severe, it may be necessary to reduce the dosage or discontinue use.

Allergic reactions, although rare, can occur. Symptoms may include skin rashes, itching, and swelling. Individuals with known allergies to Ginkgo Biloba or any of its components should avoid using the supplement. If you experience any signs of an allergic reaction, such as difficulty breathing or swelling of the face, lips, tongue, or throat, seek medical attention immediately.

Ginkgo Biloba has blood-thinning properties due to its ability to inhibit platelet-activating factor (PAF). This can increase the risk of bleeding, especially in individuals taking anticoagulant or antiplatelet medications such as warfarin, aspirin, or clopidogrel. It can also pose a risk for those with bleeding disorders or those undergoing surgery. It is important to consult a healthcare provider before taking Ginkgo Biloba if you are on blood-thinning medications or have a bleeding disorder.

In rare cases, Ginkgo Biloba has been associated with seizures, particularly in individuals with epilepsy or other seizure disorders. The seeds of the Ginkgo Biloba tree contain a toxin called ginkgotoxin, which can lower the seizure threshold. However, standardized extracts used in supplements typically have very low levels of this toxin. Nonetheless, individuals with a history of seizures should use Ginkgo Biloba with caution and under the guidance of a healthcare provider.

In conclusion, while Ginkgo Biloba is generally safe for most people, it can cause side effects such as gastrointestinal upset, headache, dizziness, and allergic reactions. It may also increase the risk of bleeding and should be used with caution in individuals with bleeding disorders or those taking blood-thinning medications. Always consult a healthcare provider before starting Ginkgo Biloba, especially if you have underlying health conditions or are taking other medications.

While Ginkgo Biloba is generally considered safe for many people, there are specific groups who should avoid taking the supplement or use it with caution. These include individuals with certain medical conditions, those taking specific medications, and pregnant or breastfeeding women.

Firstly, individuals with bleeding disorders or those who are at an increased risk of bleeding should exercise caution when taking Ginkgo Biloba. The supplement has blood-thinning properties due to its ability to inhibit platelet-activating factor (PAF), which can increase the risk of bleeding. People with conditions such as hemophilia or those with a history of bleeding or blood clotting disorders should avoid Ginkgo Biloba unless advised otherwise by a healthcare provider.

Similarly, individuals scheduled for surgery or dental procedures should discontinue the use of Ginkgo Biloba at least two weeks prior to the operation. This precaution helps minimize the risk of excessive bleeding during and after the procedure. Always inform your surgeon or dentist about any supplements you are taking.

Ginkgo Biloba can also interact with certain medications, potentially leading to adverse effects. People taking anticoagulant or antiplatelet medications, such as warfarin, aspirin, or clopidogrel, should avoid Ginkgo Biloba unless closely monitored by a healthcare professional. The combination can enhance the risk of bleeding. Additionally, Ginkgo Biloba may interact with nonsteroidal anti-inflammatory drugs (NSAIDs) and increase the risk of bleeding.

Individuals with seizure disorders, such as epilepsy, should use Ginkgo Biloba with caution. While the standardized extracts used in supplements typically contain very low levels of ginkgotoxin (a compound found in ginkgo seeds that can lower the seizure threshold), there have been reports of seizures associated with Ginkgo Biloba use. It is crucial to consult a healthcare provider before taking Ginkgo Biloba if you have a history of seizures.

Pregnant and breastfeeding women should avoid Ginkgo Biloba due to the lack of sufficient evidence regarding its safety in these populations. The potential risks to the developing fetus or nursing infant are not well understood, and it is best to err on the side of caution.

Lastly, individuals with allergies to Ginkgo Biloba or any of its components should avoid using the supplement. Allergic reactions, though rare, can manifest as skin rashes, itching, and swelling, and can be severe in some cases.

In summary, while Ginkgo Biloba is safe for many, it should be avoided by individuals with bleeding disorders, those taking anticoagulant or antiplatelet medications, people with seizure disorders, and pregnant or breastfeeding women. Always consult a healthcare provider before starting Ginkgo Biloba, especially if you have underlying health conditions or are taking other medications.

Yes, Ginkgo Biloba supplements are known to interact with several medications, which can lead to adverse effects or reduced efficacy of either the supplement or the medication. It is crucial to be aware of these potential interactions and consult a healthcare provider before starting Ginkgo Biloba, especially if you are taking other medications. Here are some of the key interactions:

1. Anticoagulants and Antiplatelet Drugs: Ginkgo Biloba has blood-thinning properties due to its inhibition of platelet-activating factor (PAF). This can increase the risk of bleeding when taken with anticoagulant medications such as warfarin (Coumadin), heparin, and direct oral anticoagulants (DOACs), as well as antiplatelet drugs like aspirin and clopidogrel (Plavix). A study published in the Journal of Clinical Pharmacology highlighted that the combination of Ginkgo Biloba with these medications could significantly elevate the risk of bleeding complications (Kudolo et al., 2002).
2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Similar to anticoagulants, NSAIDs like ibuprofen (Advil) and naproxen (Aleve) can also increase the risk of bleeding. When combined with Ginkgo Biloba, the likelihood of gastrointestinal bleeding and other bleeding events may be heightened.
3. Antidepressants: Ginkgo Biloba may interact with certain antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). Combining Ginkgo Biloba with SSRIs such as fluoxetine (Prozac) or sertraline (Zoloft) could potentially increase the risk of serotonin syndrome, a condition characterized by confusion, agitation, rapid heart rate, and high blood pressure. Additionally, a study published in Phytomedicine suggested that Ginkgo Biloba could affect the metabolism of certain antidepressants, thereby altering their efficacy (Woelk et al., 1994).
4. Anticonvulsants: Individuals taking anticonvulsant medications for seizure disorders should be cautious with Ginkgo Biloba. Although standardized extracts contain low levels of ginkgotoxin, there have been reports of seizures associated with Ginkgo Biloba use. Medications such as phenytoin (Dilantin) and valproic acid (Depakote) may have altered effectiveness when taken with Ginkgo Biloba.
5. Diabetes Medications: Ginkgo Biloba may affect blood sugar levels, potentially interfering with diabetes medications like insulin and oral hypoglycemic agents (e.g., metformin, glipizide). Monitoring blood sugar levels closely and consulting a healthcare provider is advisable when combining these treatments.
6. Blood Pressure Medications: Ginkgo Biloba may have an impact on blood pressure, potentially interfering with antihypertensive medications. It is essential to monitor blood pressure regularly and discuss any changes in medication with a healthcare provider.
7. Cytochrome P450 Enzyme Interactions: Ginkgo Biloba can influence the activity of cytochrome P450 enzymes, which are responsible for metabolizing many drugs. This interaction could affect the plasma levels of medications metabolized by these enzymes, such as certain statins, antiretrovirals, and immunosuppressants. A study in Clinical Pharmacokinetics highlighted how Ginkgo Biloba could alter the metabolism of drugs processed by CYP3A4 and CYP2C19 enzymes (Ude et al., 2013).

In conclusion, Ginkgo Biloba supplements can interact with various medications, leading to potential adverse effects or altered drug efficacy. It is essential to consult a healthcare provider before starting Ginkgo Biloba, especially if you are taking other medications, to ensure safe and effective use.

When choosing a Ginkgo Biloba supplement, it is important to consider the source and quality to ensure you are getting a product that is both effective and safe. The best sources of Ginkgo Biloba are those that use standardized extracts, such as EGb 761 or GBE (Ginkgo Biloba Extract), which ensure consistent levels of the active compounds. Here are some key factors to consider when selecting a Ginkgo Biloba supplement:

1. Standardized Extracts: Look for products that specify the use of standardized extracts, such as EGb 761 or GBE. These extracts are typically standardized to contain 24% flavone glycosides and 6% terpene lactones, which are the primary active components responsible for the supplement's therapeutic effects. Standardization ensures consistent potency and quality across different batches. A study published in the Journal of Ethnopharmacology highlighted the importance of using standardized extracts to achieve reliable health benefits (Ahlemeyer & Krieglstein, 2003).
2. Reputable Brands: Choose supplements from reputable brands that adhere to Good Manufacturing Practices (GMP) and have a history of producing high-quality products. Reputable brands often conduct third-party testing to verify the purity, potency, and safety of their supplements. Look for certifications or seals of approval from independent organizations such as NSF International, USP (United States Pharmacopeia), or ConsumerLab.
3. Ingredient Transparency: Ensure the supplement label provides clear information about the ingredients, including the specific type of Ginkgo Biloba extract used, the standardization percentage, and any additional ingredients. Avoid products with unnecessary fillers, artificial additives, or proprietary blends that do not disclose the exact amounts of active ingredients.
4. Form and Dosage: Ginkgo Biloba supplements are available in various forms, including capsules, tablets, liquid extracts, and teas. Capsules and tablets are the most common and convenient forms, offering precise dosages. Liquid extracts can be easily adjusted for dosage and may be preferred by those who have difficulty swallowing pills. Teas made from Ginkgo Biloba leaves are less common and may have variable potency compared to standardized extracts.
5. Purity and Safety: Check for potential contaminants, such as heavy metals, pesticides, and microbial impurities. Reputable brands often provide Certificates of Analysis (COAs) that confirm the absence of contaminants and verify the product's safety.
6. Customer Reviews and Testimonials: Reading customer reviews and testimonials can provide insights into the effectiveness and quality of the supplement. Look for feedback from verified purchasers and consider both positive and negative reviews to get a balanced perspective.

In summary, the best sources of Ginkgo Biloba are those that use standardized extracts like EGb 761 or GBE, come from reputable brands with transparent ingredient labeling, and undergo third-party testing for purity and safety. By considering these factors, you can choose a high-quality Ginkgo Biloba supplement that is both effective and safe for your health needs.

Ginkgo Biloba is available in various forms, each with its own advantages and considerations. The most common forms include capsules, tablets, liquid extracts, teas, and powders. Here’s a detailed look at each form:

1. Capsules and Tablets: These are the most popular and convenient forms of Ginkgo Biloba. Capsules and tablets typically contain a standardized extract, such as EGb 761, ensuring consistent levels of active compounds like flavone glycosides and terpene lactones. They offer precise dosages and are easy to incorporate into a daily supplement regimen. Capsules and tablets are also portable and have a longer shelf life compared to some other forms.
2. Liquid Extracts: Liquid extracts or tinctures are another common form of Ginkgo Biloba. These extracts are made by soaking Ginkgo Biloba leaves in alcohol or another solvent to concentrate the active compounds. Liquid extracts are versatile and can be easily added to water, juice, or other beverages. They allow for flexible dosing, which can be particularly useful for individuals who need to adjust their dosage. However, the taste of liquid extracts can be strong and may not be palatable for everyone.
3. Teas: Ginkgo Biloba tea is made from dried Ginkgo Biloba leaves and can be brewed like any other herbal tea. While teas may offer some of the benefits of Ginkgo Biloba, they generally contain lower concentrations of the active compounds compared to standardized extracts found in capsules or tablets. As a result, the therapeutic effects may be less pronounced. Teas can be a pleasant way to consume Ginkgo Biloba, especially for those who enjoy herbal beverages.
4. Powders: Ginkgo Biloba powder is made from dried and ground Ginkgo Biloba leaves. Powders can be mixed into smoothies, shakes, or other foods and beverages. Like teas, powders may have variable concentrations of active compounds and may not provide the same standardized dosage as capsules or tablets. Powders offer versatility in how they can be consumed but may require careful measuring to ensure consistent dosing.
5. Topical Applications: While less common, Ginkgo Biloba is sometimes included in topical formulations such as creams, lotions, and gels. These products are typically used for their antioxidant and anti-inflammatory properties and are applied directly to the skin. Topical applications are often marketed for improving skin health and addressing conditions like eczema or psoriasis.
6. Combination Supplements: Ginkgo Biloba is sometimes included in combination supplements that contain other herbs and nutrients. These formulations are designed to provide synergistic effects for specific health goals, such as cognitive enhancement, cardiovascular support, or stress relief. When choosing combination supplements, it’s important to ensure that each ingredient is included at an effective dosage.

In summary, Ginkgo Biloba is available in several forms, including capsules, tablets, liquid extracts, teas, powders, topical applications, and combination supplements. Each form has its own advantages and considerations, so the choice depends on individual preferences, the desired dosage, and the specific health goals. Always opt for high-quality products from reputable brands to ensure safety and efficacy.

The efficacy of Ginkgo Biloba is primarily attributed to its rich composition of bioactive compounds, particularly flavonoids and terpenoids. These sub-compounds play crucial roles in delivering the therapeutic benefits associated with Ginkgo Biloba. Here are the key sub-compounds and their contributions to the efficacy of Ginkgo Biloba:

1. Flavonoids:
   • Quercetin: This is one of the most well-known flavonoids in Ginkgo Biloba. Quercetin has potent antioxidant properties that help neutralize free radicals and reduce oxidative stress, which is implicated in aging and various neurodegenerative diseases. Its anti-inflammatory effects also contribute to the overall health benefits of Ginkgo Biloba (Ahlemeyer & Krieglstein, 2003).
   • Kaempferol: Another significant flavonoid, kaempferol, has been shown to possess anti-inflammatory, antioxidant, and anticancer properties. It helps protect cells from oxidative damage and supports overall cellular health.
   • Isorhamnetin: This flavonoid also exhibits antioxidant and anti-inflammatory properties, contributing to the neuroprotective effects of Ginkgo Biloba. It helps in maintaining vascular health and improving blood flow.
2. Terpenoids:
   • Ginkgolides: Ginkgo Biloba contains several ginkgolides (A, B, C, J), which are unique diterpenoids. Ginkgolides are known for their ability to inhibit platelet-activating factor (PAF), thus reducing the risk of blood clots and improving circulation. Ginkgolide B, in particular, has been extensively studied for its neuroprotective properties and its role in reducing inflammation and oxidative stress (Smith & Luo, 2004).
   • Bilobalide: This sesquiterpene is another critical terpenoid in Ginkgo Biloba. Bilobalide has been shown to protect neurons from damage, enhance cognitive function, and improve mitochondrial function. It also has anti-inflammatory properties and helps modulate neurotransmitter levels, which can improve mood and cognitive performance (Yoshitake et al., 2010).
3. Organic Acids:
   • Ginkgolic Acids: While these compounds are present in Ginkgo Biloba, they are generally considered undesirable due to their potential toxicity. High-quality Ginkgo Biloba extracts, such as EGb 761, are standardized to contain low levels of ginkgolic acids (less than 5 parts per million) to ensure safety.
4. Other Bioactive Compounds:
   • Proanthocyanidins: These compounds also contribute to the antioxidant activity of Ginkgo Biloba. They help protect cells from oxidative damage and support vascular health, enhancing blood flow and circulation.

The standardized extracts of Ginkgo Biloba, such as EGb 761, are designed to contain specific concentrations of these critical sub-compounds—typically 24% flavone glycosides and 6% terpene lactones. This standardization ensures consistent potency and efficacy across different batches of the supplement.

In summary, the efficacy of Ginkgo Biloba is largely due to its flavonoids (quercetin, kaempferol, isorhamnetin) and terpenoids (ginkgolides, bilobalide), which provide antioxidant, anti-inflammatory, and neuroprotective effects. These sub-compounds work synergistically to deliver the therapeutic benefits associated with Ginkgo Biloba, making standardized extracts like EGb 761 effective and reliable for various health applications.

Ginkgo Biloba is known by several names, abbreviations, and variations, reflecting its widespread use and recognition in both traditional and modern medicine. Here are some of the most common names and terms associated with Ginkgo Biloba:

1. Common Names:
   • Ginkgo: This is the most commonly used short form of Ginkgo Biloba.
   • Maidenhair Tree: This name is derived from the tree’s fan-shaped leaves, which resemble those of the maidenhair fern.
2. Scientific and Botanical Names:
   • Ginkgo Biloba: The full scientific name of the species.
   • Salisb: This is sometimes appended to the scientific name to acknowledge the botanist Richard Salisbury, who formally described the species.
3. Abbreviations:
   • GB: A common abbreviation for Ginkgo Biloba used in scientific literature and supplement labels.
   • EGb 761: This is a standardized extract of Ginkgo Biloba that contains specific concentrations of the active compounds (24% flavone glycosides and 6% terpene lactones).
4. Common Misspellings and Variations:
   • Gingko: A common misspelling that transposes the "k" and "g".
   • Ginko: A simplified misspelling that drops one of the "g"s.
   • Gingkgo: Another variation with an extra "g".
5. Chemical Compounds and Ingredients:
   • Flavonoids: These include quercetin, kaempferol, and isorhamnetin, which are potent antioxidants found in Ginkgo Biloba.
   • Terpenoids: This group includes ginkgolides (A, B, C, J) and bilobalide, which contribute to Ginkgo Biloba's neuroprotective and anti-inflammatory properties.
   • Ginkgolic Acids: While present in the raw leaves, these compounds are typically minimized in standardized extracts due to their potential toxicity.
6. Traditional Chinese Medicine (TCM) Names:
   • Bai Guo: In traditional Chinese medicine, Ginkgo Biloba seeds are known as Bai Guo, which translates to "white fruit".
7. Other Names in Different Languages:
   • Arbre aux quarante écus: French for "tree of forty coins," referring to the high price paid for Ginkgo trees during their introduction to Europe.
   • Yín Guǒ: Chinese name for the seeds.
   • Ichō: Japanese name for the Ginkgo tree.

In summary, Ginkgo Biloba is known by various names, abbreviations, and terms, including Ginkgo, Maidenhair Tree, GB, EGb 761, and several chemical compounds such as flavonoids and terpenoids. Common misspellings like Gingko and Ginko are also frequently encountered. These variations reflect the widespread use and recognition of Ginkgo Biloba across different cultures and medical traditions.

When selecting a Ginkgo Biloba supplement, it's essential to carefully examine the product label to ensure quality, efficacy, and safety. Here are the key factors to look for on the label:

1. Standardized Extract:
   • Ensure the supplement uses a standardized extract, such as EGb 761 or GBE. Standardization guarantees consistent levels of active compounds, specifically 24% flavone glycosides and 6% terpene lactones. This consistency is crucial for achieving the desired therapeutic effects. For example, a study published in Clinical Pharmacokinetics emphasizes the importance of standardized extracts for reliable health benefits (Ude et al., 2013).
2. Dosage Information:
   • Check the dosage per serving to ensure it aligns with recommended therapeutic doses. Common dosages range from 120 mg to 240 mg per day, divided into two or three doses. Make sure the label specifies the amount of Ginkgo Biloba extract per capsule or tablet to facilitate accurate dosing.
3. Ingredient Transparency:
   • The label should clearly list all ingredients, including the specific type of Ginkgo Biloba extract used, the standardization percentage, and any additional ingredients. Avoid products with proprietary blends that do not disclose the exact amounts of active ingredients, as this can make it difficult to assess the supplement's efficacy.
4. Purity and Safety:
   • Look for information on potential contaminants, such as heavy metals, pesticides, and microbial impurities. Reputable brands often provide Certificates of Analysis (COAs) that confirm the absence of contaminants and verify the product's safety. Certifications from independent organizations such as NSF International, USP (United States Pharmacopeia), or ConsumerLab can also indicate high quality and safety standards.
5. Third-Party Testing:
   • Choose supplements that have undergone third-party testing. Independent testing verifies the supplement's potency, purity, and safety, providing an additional layer of assurance. Third-party tested products often display certification seals on their labels.
6. Manufacturer Information:
   • The label should include information about the manufacturer, including their name, address, and contact details. Reputable manufacturers adhere to Good Manufacturing Practices (GMP) and have a history of producing high-quality supplements. Researching the manufacturer can provide insights into their reputation and quality standards.
7. Expiration Date and Batch Number:
   • Check the expiration date to ensure the supplement is fresh and effective. The batch number is also important, as it allows for traceability in case of recalls or quality issues.
8. Potential Allergens:
   • Review the label for any potential allergens, such as gluten, soy, or dairy. This is particularly important for individuals with specific dietary restrictions or sensitivities.
9. Usage Instructions:
   • The label should provide clear instructions on how to take the supplement, including the recommended dosage, timing, and whether it should be taken with food. Follow these instructions to maximize the supplement's effectiveness.

In summary, when choosing a Ginkgo Biloba supplement, look for standardized extracts, clear dosage information, ingredient transparency, purity and safety certifications, third-party testing, reputable manufacturer details, expiration date and batch number, potential allergens, and usage instructions. By carefully examining the label for these factors, you can ensure you are selecting a high-quality Ginkgo Biloba supplement that is safe and effective for your health needs.

The information provided on this website, including any text, images, or other material contained within, is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. This page was created by the SuppCo editiorial team, with AI summarization tools, including data from but not limited to following studies:

1. J. T. Berg (2004). Ginkgo biloba extract prevents high altitude pulmonary edema in rats.. High altitude medicine & biology, 5 4,
   429-34 . Link: 10.1089/HAM.2004.5.429
2. Casey Jowers, Richard Shih, Jim James, T. Deloughery, W. Holden (2004). Effects of Ginkgo biloba on exhaled nasal nitric oxide during normobaric hypoxia in humans.. High altitude medicine & biology, 5 4,
   445-9 . Link: 10.1089/HAM.2004.5.445
3. J. Roncin, F. Schwartz, P. D'arbigny (1996). EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure.. Aviation, space, and environmental medicine, 67 5,
   445-52 . Link:
4. M. T. V. van Patot, L. Keyes, G. Leadbetter, P. Hackett (2009). Ginkgo biloba for prevention of acute mountain sickness: does it work?. High altitude medicine & biology, 10 1,
   33-43 . Link: 10.1089/ham.2008.1085
5. Jeffrey H. Gertsch, B. Basnyat, E. Johnson, J. Onopa, Peter S. Holck (2004). Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ : British Medical Journal, 328, 797. Link: 10.1136/bmj.38043.501690.7C
6. Jeffrey H. Gertsch, T. Seto, J. Mor, J. Onopa (2002). Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent.. High altitude medicine & biology, 3 1,
   29-37 . Link: 10.1089/152702902753639522
7. Tou-Yuan Tsai, Shih-Hao Wang, Yi-Kung Lee, Yung-Cheng Su (2018). Ginkgo biloba extract for prevention of acute mountain sickness: a systematic review and meta-analysis of randomised controlled trials. BMJ Open, 8, . Link: 10.1136/bmjopen-2018-022005
8. F. Moraga, A. Flores, J. Serra, Carla Esnaola, Corina Barriento (2007). Ginkgo biloba Decreases Acute Mountain Sickness in People Ascending to High Altitude at Ollagüe (3696 m) in Northern Chile. {"title"=>"", "scimago_quartile"=>nil}, 18, 251 - 257. Link: 10.1580/06-WEME-OR-062R2.1
9. Tony Chow, V. Browne, H. L. Heileson, D. Wallace, J. Anholm, S. Green (2005). Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.. Archives of internal medicine, 165 3,
   296-301 . Link: 10.1001/ARCHINTE.165.3.296
10. G. Leadbetter, L. Keyes, Kirsten M. Maakestad, Sheryl Olson, M. C. Tissot van Patot, P. Hackett (2009). Ginkgo biloba Does—and Does Not—Prevent Acute Mountain Sickness. {"title"=>"", "scimago_quartile"=>nil}, 20, 66 - 71. Link: 10.1580/08-WEME-BR-247.1
11. S. Weinmann, S. Roll, C. Schwarzbach, C. Vauth, S. Willich (2010). Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatrics, 10, 14 - 14. Link: 10.1186/1471-2318-10-14
12. K. Maurer, R. Ihl, T. Dierks, L. Frölich (1997). Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.. Journal of psychiatric research, 31 6,
    645-55 . Link: 10.1016/S0022-3956(97)00022-8
13. Chaugule Afroz N., Aswale Ashwini E., Datkhile Sachin V. (2022). Role of Ginkgo Biloba in Alzheimer Disease. International Journal of Advanced Research in Science, Communication and Technology, , . Link: 10.48175/ijarsct-4963
14. B. Vellas, N. Coley, P. Ousset, G. Berrut, J. Dartigues, B. Dubois, H. Grandjean, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet, S. Andrieu (2012). Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology, 11, 851-859. Link: 10.1016/S1474-4422(12)70206-5
15. Hongxiang Li, Xiaoyuan Sun, F. Yu, Lijia Xu, J. Miu, P. Xiao (2018). In Silico Investigation of the Pharmacological Mechanisms of Beneficial Effects of Ginkgo biloba L. on Alzheimer’s Disease. Nutrients, 10, . Link: 10.3390/nu10050589
16. S. Singh, S. Srivastav, R. Castellani, G. Plascencia‐Villa, George Perry (2019). Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics, 16, 666 - 674. Link: 10.1007/s13311-019-00767-8
17. Haolong Liu, M. Ye, Hongzhu Guo (2020). An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer’s Patients. Frontiers in Pharmacology, 10, . Link: 10.3389/fphar.2019.01688
18. M. Tan, Jin-Tai Yu, Chen‐Chen Tan, Huifu Wang, Xiang-Fei Meng, Chong Wang, Teng Jiang, Xi-Chen Zhu, L. Tan (2014). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.. Journal of Alzheimer's disease : JAD, 43 2,
    589-603 . Link: 10.3233/JAD-140837
19. Guoyan Yang, Yu-yi Wang, Jin Sun, Kang Zhang, Jianpin Liu (2015). Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Current topics in medicinal chemistry, 16 5,
    520-8 . Link: 10.2174/1568026615666150813143520
20. Li-ming Xie, Qi Zhu, Jiahong Lu (2022). Can We Use Ginkgo biloba Extract to Treat Alzheimer’s Disease? Lessons from Preclinical and Clinical Studies. Cells, 11, . Link: 10.3390/cells11030479
21. Yu-zhou Wu, Shu-qin Li, Xiu-guang Zu, Jun Du, Fengfei Wang (2008). Ginkgo biloba extract improves coronary artery circulation in patients with coronary artery disease: contribution of plasma nitric oxide and endothelin‐1. Phytotherapy Research, 22, . Link: 10.1002/ptr.2335
22. F. Jung, C. Mrowietz, H. Kiesewetter, E. Wenzel* (1990). Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers.. Arzneimittel-Forschung, 40 5,
    589-93 . Link:
23. J. Evans (2013). Ginkgo biloba extract for age-related macular degeneration.. The Cochrane database of systematic reviews, 1,
    CD001775 . Link: 10.1002/14651858.CD001775.pub2
24. Wang Feng-fei (2009). Effects of Ginkgo biloba Extract on Coronary Blood Flow,Plasma Nitric Oxide and Endothelin Levels in Postmenopausal Women with Coronary Artery Disease. Lishizhen Medicine and Materia Medica Research, , . Link:
25. J. Krieglstein, T. Beck, A. Seibert (1986). Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism.. Life sciences, 39 24,
    2327-34 . Link: 10.1016/0024-3205(86)90663-6
26. B. Ahlemeyer, J. Krieglstein (2003). Neuroprotective effects of Ginkgo biloba extract. Cellular and Molecular Life Sciences CMLS, 60, 1779-1792. Link: 10.1007/s00018-003-3080-1
27. H. Chung, A. Harris, J. Kristinsson, T. Ciulla, Carol Kagemann, R. Ritch (1999). Ginkgo biloba extract increases ocular blood flow velocity.. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 15 3,
    233-40 . Link: 10.1089/JOP.1999.15.233
28. Yu-zhou Wu, Shu-qin Li, W. Cui, Xiu-guang Zu, Jun Du, Fengfei Wang (2008). Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium-dependent vasodilation.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 15 3,
    164-9 . Link: 10.1016/j.phymed.2007.12.002
29. B. Wimpissinger, F. Berisha, G. Garhoefer, K. Polak, L. Schmetterer (2007). Influence of Ginkgo biloba on ocular blood flow.. Acta ophthalmologica Scandinavica, 85 4,
    445-9 . Link: 10.1111/J.1600-0420.2007.00887.X
30. E. Boelsma, R. Lamers, H. Hendriks, J. H. V. van Nesselrooij, L. Roza (2004). Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans.. Planta medica, 70 11,
    1052-7 . Link: 10.1055/S-2004-832646
31. B. Ahlemeyer, J. Krieglstein (2003). Neuroprotective effects of Ginkgo biloba extract. Cellular and Molecular Life Sciences CMLS, 60, 1779-1792. Link: 10.1007/s00018-003-3080-1
32. J. Krieglstein, T. Beck, A. Seibert (1986). Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism.. Life sciences, 39 24,
    2327-34 . Link: 10.1016/0024-3205(86)90663-6
33. J. Evans (2013). Ginkgo biloba extract for age-related macular degeneration.. The Cochrane database of systematic reviews, 1,
    CD001775 . Link: 10.1002/14651858.CD001775.pub2
34. Baoliang Sun, Jian Zhang, Xingsheng Wang, Z. Xia, Ming-feng Yang, Su-ming Zhang, W. Ye, Hui Yuan (2003). Effects of extract of Ginkgo biloba on spasms of the basilar artery and cerebral microcirculatory perfusion in rats with subarachnoid hemorrhage.. Clinical hemorheology and microcirculation, 29 3-4,
    231-8 . Link:
35. A. Mashayekh, D. Pham, D. Yousem, Mercedes Dizon, P. Barker, D. Lin (2011). Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology, 53, 185-191. Link: 10.1007/s00234-010-0790-6
36. J. Krieglstein, Franz Ausmeier, H. El-Abhar, K. Lippert, M. Welsch, Katrin Rupalla, P. Henrich-Noack (1995). Neuroprotective effects of Ginkgo biloba constituents. European Journal of Pharmaceutical Sciences, 3, 39-48. Link: 10.1016/0928-0987(94)00073-9
37. Zeynep Aktürk, E. Odacı, Ayşe Ikinci, O. Baş, S. Canpolat, S. Çolakoğlu, O. Sönmez (2014). Effect of Ginkgo biloba on brain volume after carotid artery occlusion in rats: a stereological and histopathological study.. Turkish journal of medical sciences, 44 4,
    546-53 . Link: 10.3906/SAG-1305-40
38. Baoliang Sun, Hui Yuan, Ming-feng Yang, Z. Xia, Su-ming Zhang, Le-Xin Wang (2007). EFFECTS OF EXTRACT OF GINKGO BILOBA ON INTRACRANIAL PRESSURE, CEREBRAL PERFUSION PRESSURE, AND CEREBRAL BLOOD FLOW IN A RAT MODEL OF SUBARACHNOID HAEMORRHAGE. International Journal of Neuroscience, 117, 655 - 665. Link: 10.1080/00207450600773871
39. Lili Xu, Zhiyong Hu, Jianjun Shen, P. McQuillan (2015). Effects of Ginkgo biloba extract on cerebral oxygen and glucose metabolism in elderly patients with pre-existing cerebral ischemia.. Complementary therapies in medicine, 23 2,
    220-5 . Link: 10.1016/j.ctim.2014.12.009
40. B. Sun, Z. Xia, M. F. Yang, P. Qiu (2000). Effects of Ginkgo biloba extract on somatosensory evoked potential, nitric oxide levels in serum and brain tissue in rats with cerebral vasospasm after subarachnoid hemorrhage.. Clinical hemorheology and microcirculation, 23 2-4,
    139-44 . Link:
41. Jan Kehr, S. Yoshitake, S. Ijiri, E. Koch, M. Nöldner, T. Yoshitake (2012). Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®. International Psychogeriatrics, 24, S25 - S34. Link: 10.1017/S1041610212000567
42. J. Birks, J. Grimley Evans (2009). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
    CD003120 . Link: 10.1002/14651858.CD003120.pub3
43. Grimley Evans, Van Dongen (2007). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 2,
    CD003120 . Link: 10.1002/14651858.cd003120.pub2
44. M. Tan, Jin-Tai Yu, Chen‐Chen Tan, Huifu Wang, Xiang-Fei Meng, Chong Wang, Teng Jiang, Xi-Chen Zhu, L. Tan (2014). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.. Journal of Alzheimer's disease : JAD, 43 2,
    589-603 . Link: 10.3233/JAD-140837
45. D. Kennedy, A. Scholey, K. Wesnes (2000). The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology, 151, 416-423. Link: 10.1007/s002130000501
46. J. Mix, W. D. Crews (2000). An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.. Journal of alternative and complementary medicine, 6 3,
    219-29 . Link: 10.1089/ACM.2000.6.219
47. Derek Ong Lai Teik, Xiaoying Lee, Chu Jian Lim, C. M. Low, Mariyam Muslima, Luca Aquili (2016). Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity: A Randomised Trial. PLoS ONE, 11, . Link: 10.1371/journal.pone.0150447
48. T. Yoshitake, S. Yoshitake, J. Kehr (2010). The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. British Journal of Pharmacology, 159, . Link: 10.1111/j.1476-5381.2009.00580.x
49. Haolong Liu, M. Ye, Hongzhu Guo (2020). An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer’s Patients. Frontiers in Pharmacology, 10, . Link: 10.3389/fphar.2019.01688
50. Guoyan Yang, Yu-yi Wang, Jin Sun, Kang Zhang, Jianpin Liu (2015). Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Current topics in medicinal chemistry, 16 5,
    520-8 . Link: 10.2174/1568026615666150813143520
51. J. Gruenwald, A. Eckert, R. Kressig (2020). The Effects of Standardized Ginkgo Biloba Extracts (GBE) on Subjective Cognitive Decline (SCD) in Middle-Aged Adults: A Review. Advances in Aging Research, 9, 45-65. Link: 10.4236/aar.2020.93005
52. B. Snitz, E. O'Meara, M. Carlson, A. Arnold, D. Ives, S. Rapp, J. Saxton, O. Lopez, L. Dunn, K. Sink, S. DeKosky (2009). Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.. JAMA, 302 24,
    2663-70 . Link: 10.1001/jama.2009.1913
53. Stefanie Beck, Hannes Ruge, C. Schindler, M. Burkart, Robert Miller, C. Kirschbaum, T. Goschke (2016). Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment – a randomized double‐blind placebo‐controlled trial. Human Psychopharmacology, 31, 227 - 242. Link: 10.1002/hup.2534
54. Grimley Evans, Van Dongen (2007). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 2,
    CD003120 . Link: 10.1002/14651858.cd003120.pub2
55. J. Birks, J. Grimley Evans (2009). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
    CD003120 . Link: 10.1002/14651858.CD003120.pub3
56. M. Tan, Jin-Tai Yu, Chen‐Chen Tan, Huifu Wang, Xiang-Fei Meng, Chong Wang, Teng Jiang, Xi-Chen Zhu, L. Tan (2014). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.. Journal of Alzheimer's disease : JAD, 43 2,
    589-603 . Link: 10.3233/JAD-140837
57. H. Dodge, T. Zitzelberger, B. Oken, D. Howieson, J. Kaye (2008). A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology, 70, 1809 - 1817. Link: 10.1212/01.wnl.0000303814.13509.db
58. Hong-feng Zhang, Li-Bo Huang, Yan-Biao Zhong, Qi-Hui Zhou, Hui-Lin Wang, Guo-qing Zheng, Yan Lin (2016). An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia. Frontiers in Aging Neuroscience, 8, . Link: 10.3389/fnagi.2016.00276
59. C. Ude, M. Schubert-Zsilavecz, M. Wurglics (2013). Ginkgo biloba Extracts: A Review of the Pharmacokinetics of the Active Ingredients. Clinical Pharmacokinetics, 52, 727-749. Link: 10.1007/s40262-013-0074-5
60. G. Thomson, R. Vohra, M. Carr, M. Walker (1990). A clinical trial of Gingkco Biloba Extract in patients with intermittent claudication.. International angiology : a journal of the International Union of Angiology, 9 2,
    75-8 . Link:
61. H. Peters, M. Kieser, U. Hölscher (1998). Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.. VASA. Zeitschrift fur Gefasskrankheiten, 27 2,
    106-10 . Link: 10.1016/s0965-2299(99)80065-x
62. H. Drabaek, J. Petersen, N. Wïnberg, K. W. Hansen, J. Mehlsen (1996). [The effect of Ginkgo biloba extract in patients with intermittent claudication].. Ugeskrift for laeger, 158 27,
    3928-31 . Link:
63. E. Ernst (1996). [Ginkgo biloba in treatment of intermittent claudication. A systematic research based on controlled studies in the literature].. Fortschritte der Medizin, 114 8,
    85-7 . Link:
64. S. P. Nicolaï, V. C. Gerardu, L. M. Kruidenier, M. Prins, J. Teijink (2010). From the Cochrane library: Ginkgo biloba for intermittent claudication.. VASA. Zeitschrift fur Gefasskrankheiten, 39 2,
    153-8 . Link: 10.1024/0301-1526/a000021
65. M. Pittler, E. Ernst (2000). Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials.. The American journal of medicine, 108 4,
    276-81 . Link: 10.1016/S0002-9343(99)00454-4
66. S. P. Nicolaï, L. M. Kruidenier, B. Bendermacher, M. Prins, R. Stokmans, P. Broos, J. Teijink (2013). Ginkgo biloba for intermittent claudication.. The Cochrane database of systematic reviews, 6,
    CD006888 . Link: 10.1002/14651858.CD006888.pub3
67. D. Moher, B. Pham, M. Ausejo, A. Sáenz, S. Hood, G. Barber (2000). Pharmacological management of intermittent claudication: a meta-analysis of randomised trials.. Drugs, 59 5,
    1057-70 . Link:
68. J. Birks, J. Grimley Evans (2009). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
    CD003120 . Link: 10.1002/14651858.CD003120.pub3
69. P. Moulton, Leon N. Boyko, J. L. Fitzpatrick, T. Petros (2001). The effect of Ginkgo biloba on memory in healthy male volunteers. Physiology & Behavior, 73, 659-665. Link: 10.1016/S0031-9384(01)00510-8
70. S. DeKosky, A. Fitzpatrick, D. Ives, J. Saxton, J. Williamson, O. Lopez, G. Burke, L. Fried, L. Kuller, J. Robbins, R. Tracy, N. Woolard, L. Dunn, R. Kronmal, R. Nahin, C. Furberg (2006). The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.. Contemporary clinical trials, 27 3,
    238-53 . Link: 10.1016/J.CCT.2006.02.007
71. Grimley Evans, Van Dongen (2007). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 2,
    CD003120 . Link: 10.1002/14651858.cd003120.pub2
72. R. Kaschel (2007). Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 18 14,
    1202-7 . Link: 10.1016/j.phymed.2011.06.021
73. K. Wesnes, T. Ward, A. Mcginty, O. Petrini (2000). The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 152, 353-361. Link: 10.1007/s002130000533
74. H. Semlitsch, P. Anderer, B. Saletu, Binder Ga, Decker Ka (1995). Cognitive Psychophysiology in Nootropic Drug Research: Effects of Ginkgo biloba on Event-related Potentials (P300) in Age-associated Memory Impairment. Pharmacopsychiatry, 28, 134 - 142. Link: 10.1055/s-2007-979605
75. U. Rigney, S. Kimber, I. Hindmarch (1999). The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytotherapy Research, 13, . Link: 10.1002/(SICI)1099-1573(199908/09)13:5<408::AID-PTR530>3.0.CO;2-C
76. B. Vellas, N. Coley, P. Ousset, G. Berrut, J. Dartigues, B. Dubois, H. Grandjean, F. Pasquier, F. Piette, P. Robert, J. Touchon, P. Garnier, H. Mathiex-Fortunet, S. Andrieu (2012). Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology, 11, 851-859. Link: 10.1016/S1474-4422(12)70206-5
77. S. Weinmann, S. Roll, C. Schwarzbach, C. Vauth, S. Willich (2010). Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatrics, 10, 14 - 14. Link: 10.1186/1471-2318-10-14
78. H. Kobuchi, M. Droy-lefaix, Y. Christen, L. Packer (1997). Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7.. Biochemical pharmacology, 53 6,
    897-903 . Link: 10.1016/S0006-2952(96)00873-8
79. L. Marcocci, J. Maguire, M. Droy-lefaix, L. Packer (1994). The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761.. Biochemical and biophysical research communications, 201 2,
    748-55 . Link: 10.1006/BBRC.1994.1764
80. F. Cheung, Y. Siow, Wei Z Chen, K. O (1999). Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells.. Biochemical pharmacology, 58 10,
    1665-73 . Link: 10.1016/S0006-2952(99)00255-5
81. Teri L. Wadsworth, D. R. Koop (2001). Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide.. Chemico-biological interactions, 137 1,
    43-58 . Link: 10.1016/S0009-2797(01)00208-3
82. S. Bastianetto, W. Zheng, R. Quirion (2000). The Ginkgo biloba Extract (EGb 761) Protects and Rescues Hippocampal Cells Against Nitric Oxide‐Induced Toxicity. Journal of Neurochemistry, 74, . Link: 10.1046/j.1471-4159.2000.0742268.x
83. G. Calapai, A. Crupi, F. Firenzuoli, M. Marciano, F. Squadrito, G. Inferrera, A. Parisi, A. Rizzo, C. Crisafulli, A. Fiore, A. Caputi (2000). Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis.. Life sciences, 67 22,
    2673-83 . Link: 10.1016/S0024-3205(00)00858-4
84. F. Cheung, Y. Siow, K. O (2001). Inhibition by ginkgolides and bilobalide of the production of nitric oxide in macrophages (THP-1) but not in endothelial cells (HUVEC).. Biochemical pharmacology, 61 4,
    503-10 . Link: 10.1016/S0006-2952(00)00567-0
85. Casey Jowers, Richard Shih, Jim James, T. Deloughery, W. Holden (2004). Effects of Ginkgo biloba on exhaled nasal nitric oxide during normobaric hypoxia in humans.. High altitude medicine & biology, 5 4,
    445-9 . Link: 10.1089/HAM.2004.5.445
86. Ke-xuan Liu, Wei-Kang Wu, Wei He, Chui-liang Liu (2007). Ginkgo biloba extract (EGb 761) attenuates lung injury induced by intestinal ischemia/reperfusion in rats: roles of oxidative stress and nitric oxide.. World journal of gastroenterology, 13 2,
    299-305 . Link: 10.3748/WJG.V13.I2.299
87. O. G. Adebayo, W. Aduema, A. Iwueke, J. N. Asiwe, Ijeoma Onyeleonu, Ajirioghene E. Akpotu, I. Wopara, O. R. Adebayo, O. Onuoha, Emeka Spiff Eleazar, Favour C Onwuka (2022). Treatment with Ginkgo biloba supplement modulates oxidative disturbances, inflammation and vascular functions in oxygen deprived hypothyroid mice: Involvement of endothelin-1/NO signaling pathways.. Journal of food biochemistry, ,
    e14477 . Link: 10.1111/jfbc.14477
88. J. M. Kang, Shan C. Lin (2017). Ginkgo biloba and its potential role in glaucoma. Current Opinion in Ophthalmology, 29, 116–120. Link: 10.1097/ICU.0000000000000459
89. B. Wimpissinger, F. Berisha, G. Garhoefer, K. Polak, L. Schmetterer (2007). Influence of Ginkgo biloba on ocular blood flow.. Acta ophthalmologica Scandinavica, 85 4,
    445-9 . Link: 10.1111/J.1600-0420.2007.00887.X
90. H. Chung, A. Harris, J. Kristinsson, T. Ciulla, Carol Kagemann, R. Ritch (1999). Ginkgo biloba extract increases ocular blood flow velocity.. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 15 3,
    233-40 . Link: 10.1089/JOP.1999.15.233
91. J. Evans (2013). Ginkgo biloba extract for age-related macular degeneration.. The Cochrane database of systematic reviews, 1,
    CD001775 . Link: 10.1002/14651858.CD001775.pub2
92. Jong Woon Park, H. J. Kwon, Woosuk Chung, C. Kim, G. Seong (2011). Short-Term Effects of Ginkgo biloba Extract on Peripapillary Retinal Blood Flow in Normal Tension Glaucoma. Korean Journal of Ophthalmology : KJO, 25, 323 - 328. Link: 10.3341/kjo.2011.25.5.323
93. J. Krieglstein, T. Beck, A. Seibert (1986). Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism.. Life sciences, 39 24,
    2327-34 . Link: 10.1016/0024-3205(86)90663-6
94. B. Ahlemeyer, J. Krieglstein (2003). Neuroprotective effects of Ginkgo biloba extract. Cellular and Molecular Life Sciences CMLS, 60, 1779-1792. Link: 10.1007/s00018-003-3080-1
95. A. Mashayekh, D. Pham, D. Yousem, Mercedes Dizon, P. Barker, D. Lin (2011). Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology, 53, 185-191. Link: 10.1007/s00234-010-0790-6
96. E. Boelsma, R. Lamers, H. Hendriks, J. H. V. van Nesselrooij, L. Roza (2004). Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans.. Planta medica, 70 11,
    1052-7 . Link: 10.1055/S-2004-832646
97. Eman Gamal, E. Aly, S. Mahmoud, M. Talaat, A. Sallam (2011). FTIR Assessment of the Effect of Ginkgo biloba Leave Extract (EGb 761) on Mammalian Retina. Cell Biochemistry and Biophysics, 61, 169-177. Link: 10.1007/s12013-011-9173-9
98. Juntao Kan, Junrui Cheng, Chun Hu, Liang Chen, Siyu Liu, D. Venzon, Mary A. Murray, Shu-guang Li, Jun Du (2021). A Botanical Product Containing Cistanche and Ginkgo Extracts Potentially Improves Chronic Fatigue Syndrome Symptoms in Adults: A Randomized, Double-Blind, and Placebo-Controlled Study. Frontiers in Nutrition, 8, . Link: 10.3389/fnut.2021.658630
99. A. Tamborini, R. Taurelle (1993). [Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome].. Revue francaise de gynecologie et d'obstetrique, 88 7-9,
    447-57 . Link:
100. Gabriela Achete de Souza, Sâmylla Vaz de Marqui, Júlia Novaes Matias, É. Guiguer, S. Barbalho (2020). Effects of Ginkgo biloba on Diseases Related to Oxidative Stress. Planta Medica, 86, 376 - 386. Link: 10.1055/a-1109-3405
101. J. Evans (2013). Ginkgo biloba extract for age-related macular degeneration.. The Cochrane database of systematic reviews, 1,
     CD001775 . Link: 10.1002/14651858.CD001775.pub2
102. N. Mohamed, A. Abd El-moneim (2017). Ginkgo biloba extract alleviates oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats.. Nutrition, 35,
     93-99 . Link: 10.1016/j.nut.2016.10.012
103. G. Ozgoli, E. Selselei, F. Mojab, H. Majd (2009). A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome.. Journal of alternative and complementary medicine, 15 8,
     845-51 . Link: 10.1089/acm.2008.0493
104. E. Savaskan, H. Mueller, R. Hoerr, A. von Gunten, S. Gauthier (2017). Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. International Psychogeriatrics, 30, 285 - 293. Link: 10.1017/S1041610217001892
105. Farhad Eisvand, B. Razavi, H. Hosseinzadeh (2020). The effects of Ginkgo biloba on metabolic syndrome: A review.. Phytotherapy research : PTR, , . Link: 10.1002/ptr.6646
106. J. Birks, J. Grimley Evans (2009). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
     CD003120 . Link: 10.1002/14651858.CD003120.pub3
107. Grimley Evans, Van Dongen (2007). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 2,
     CD003120 . Link: 10.1002/14651858.cd003120.pub2
108. J. Birks, J. Grimley Evans (2009). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
     CD003120 . Link: 10.1002/14651858.CD003120.pub3
109. S. Barbalho, R. Direito, LUCAS FORNARI LAURINDO, L. Marton, É. Guiguer, R. Goulart, R. J. Tofano, A. C. A. Carvalho, U. Flato, Viviane Alessandra Capelluppi Tofano, C. Detregiachi, P. C. S. Bueno, R. J. Girio, A. Araújo (2022). Ginkgo biloba in the Aging Process: A Narrative Review. Antioxidants, 11, . Link: 10.3390/antiox11030525
110. E. Winter (1991). Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacology Biochemistry and Behavior, 38, 109-114. Link: 10.1016/0091-3057(91)90597-U
111. Isaac Duah Boateng, Wenxue Zhang, Yuanyang Li, F. Saalia, Xiao-Ming Yang (2021). Non-thermal pretreatment affects Ginkgo biloba L. seed's product qualities, sensory, and physicochemical properties.. Journal of food science, , . Link: 10.1111/1750-3841.15999
112. J. Polich, R. Gloria (2001). Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. Human Psychopharmacology: Clinical and Experimental, 16, . Link: 10.1002/hup.308
113. Jonathan W. Page, J. Findley, M. Crognale (2005). Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.. The journals of gerontology. Series A, Biological sciences and medical sciences, 60 10,
     1246-51 . Link: 10.1093/GERONA/60.10.1246
114. Isaac Duah Boateng, Xiao-Ming Yang (2020). Effect of different drying methods on product quality, bioactive and toxic components of Ginkgo biloba L. seed.. Journal of the science of food and agriculture, , . Link: 10.1002/jsfa.10958
115. D. Kennedy, A. Scholey, K. Wesnes (2000). The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology, 151, 416-423. Link: 10.1007/s002130000501
116. H. Allain, P. Raoul, A. Lieury, F. Lecoz, J. Gandon, P. D'arbigny (1993). Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.. Clinical therapeutics, 15 3,
     549-58 . Link:
117. J. Mix, W. D. Crews (2000). An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.. Journal of alternative and complementary medicine, 6 3,
     219-29 . Link: 10.1089/ACM.2000.6.219
118. W. Zhang, Yunlong Tan, X. Zhang, R. Chan, H. Wu, D. Zhou (2011). Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial.. The Journal of clinical psychiatry, 72 5,
     615-21 . Link: 10.4088/JCP.09m05125yel
119. X. Zhang, D. Zhou, P. Zhang, G. Wu, Jian-min Su, L. Cao (2001). A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.. The Journal of clinical psychiatry, 62 11,
     878-83 . Link: 10.4088/JCP.V62N1107
120. Cheng Youf, Li Yongqiang (2004). Application of Extract of Ginkgo Biloba in Psychiatric Medicine. Medical Journal of Chinese People Heacth, , . Link:
121. Wei Zhang, Shouxin Liu (2015). Study on the determination of lactone contents in Ginkgo biloba leaves andtheir effects in schizophrenia.. Biomedical Research-tokyo, 26, 0. Link:
122. N. Brondino, A. de Silvestri, Simona Re, Niccolò Lanati, Pia Thiemann, A. Verna, E. Emanuele, P. Politi (2013). A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine. Evidence-based Complementary and Alternative Medicine : eCAM, 2013, . Link: 10.1155/2013/915691
123. M. Nikfarjam, I. Goodarzi, S. Arshad, N. Parvin, F. S. Dehcheshmeh (2012). EFFECT OF GINKGO BILOBA, RISPERIDONE AND BIPERIDEN REGIMEN IN CHRONIC SCHIZOPHRENIA. Journal of Gorgan University of Medical Sciences, 14, 23-29. Link:
124. Wei Zheng, Y. Xiang, Chee H. Ng, Gabor S. Ungvari, H. Chiu, Yu-Tao Xiang (2016). Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials. Pharmacopsychiatry, 49, 107 - 111. Link: 10.1055/s-0042-102884
125. X. Zhang, D. Zhou, Jian-min Su, P. Zhang (2001). The Effect of Extract of Ginkgo Biloba Added to Haloperidol on Superoxide Dismutase in Inpatients With Chronic Schizophrenia. Journal of Clinical Psychopharmacology, 21, 85-88. Link: 10.1097/00004714-200102000-00015
126. M. Atmaca, E. Tezcan, M. Kuloğlu, B. Ustundag, Ozlem Kirtas (2005). The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia. Psychiatry and Clinical Neurosciences, 59, . Link: 10.1111/j.1440-1819.2005.01432.x
127. A. Doruk, Ö. Uzun, A. Özşahin (2008). A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia. International Clinical Psychopharmacology, 23, 223-227. Link: 10.1097/YIC.0b013e3282fcff2f
128. S. Barbalho, R. Direito, LUCAS FORNARI LAURINDO, L. Marton, É. Guiguer, R. Goulart, R. J. Tofano, A. C. A. Carvalho, U. Flato, Viviane Alessandra Capelluppi Tofano, C. Detregiachi, P. C. S. Bueno, R. J. Girio, A. Araújo (2022). Ginkgo biloba in the Aging Process: A Narrative Review. Antioxidants, 11, . Link: 10.3390/antiox11030525
129. B. Murray, P. Cowen, A. Sharpley (2001). The Effect of Li 1370, Extract of Ginkgo biloba, on REM Sleep in Humans. Pharmacopsychiatry, 34, 155 - 157. Link: 10.1055/S-2001-15876
130. S. Nishimon, Mai Yamaguchi, H. Muraki, N. Sakai, S. Nishino (2020). Intraperitoneal injection of ginkgolide B, a major active compound of Ginkgo biloba, dose-dependently increases the amount of wake and decreases non-rapid eye movement sleep in C57BL/6 mice. Neuroscience Letters, 722, . Link: 10.1016/j.neulet.2020.134832
131. Akbari Torkestani Naimeh, Davoodabadi Farahani Masoomeh, Akbari Torkestani Narges (2017). Studying the effect of Ginkgo on sleep quality of working midwiferies in hospital. Annals of Tropical Medicine and Public Health, 10, 923 - 927. Link: 10.4103/ATMPH.ATMPH_251_17
132. Sindisiwe Mazibuko (2018). The efficacy of a herbal complex (Gingko biloba, Panax ginseng, Bacopa monerii and Rhodiola rosea) in the management of excessive daytime sleepiness. {"title"=>"", "scimago_quartile"=>nil}, , . Link: 10.51415/10321/3153
133. S. M. Cockle, S. Kimber, I. Hindmarch (2000). The effects of Ginkgo biloba extract (LI 1370) supplementation on activities of daily living in free living older volunteers: a questionnaire survey. Human Psychopharmacology: Clinical and Experimental, 15, . Link: 10.1002/1099-1077(200006)15:4<227::AID-HUP208>3.0.CO;2-M
134. K. Wada, K. Sasaki, K. Miura, M. Yagi, Y. Kubota, T. Matsumoto, M. Haga (1993). Isolation of bilobalide and ginkgolide A from Ginkgo biloba L. shorten the sleeping time induced in mice by anesthetics.. Biological & pharmaceutical bulletin, 16 2,
     210-2 . Link: 10.1248/BPB.16.210
135. K. Wesnes, T. Ward, A. Mcginty, O. Petrini (2000). The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 152, 353-361. Link: 10.1007/s002130000533
136. Y. Kubota, Kyoko Kobayashi, N. Tanaka, Kazuki Nakamura, M. Kunitomo, K. Shinozuka, Y. Kubota, M. Kunitomo, K. Shinozuka, K. Umegaki (2004). Pretreatment with Ginkgo biloba extract weakens the hypnosis action of phenobarbital and its plasma concentration in rats. Journal of Pharmacy and Pharmacology, 56, . Link: 10.1211/0022357022836
137. N. Mohamed, A. Abd El-moneim (2017). Ginkgo biloba extract alleviates oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats.. Nutrition, 35,
     93-99 . Link: 10.1016/j.nut.2016.10.012
138. A. Cieza, P. Maier, E. Pöppel (2003). Effects of Ginkgo biloba on mental functioning in healthy volunteers.. Archives of medical research, 34 5,
     373-81 . Link: 10.1016/J.ARCMED.2003.05.001
139. S. Singh, G. Barreto, G. Aliev, V. Echeverria (2017). Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders.. Current drug metabolism, 18 2,
     112-119 . Link: 10.2174/1389200217666161201112206
140. E. Sadowska-Krępa, B. Kłapcińska, I. Pokora, Przemysław Domaszewski, K. Kempa, T. Podgórski (2017). Effects of Six-Week Ginkgo biloba Supplementation on Aerobic Performance, Blood Pro/Antioxidant Balance, and Serum Brain-Derived Neurotrophic Factor in Physically Active Men. Nutrients, 9, . Link: 10.3390/nu9080803
141. N. Mohamed, A. Abd El-moneim (2017). Ginkgo biloba extract alleviates oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats.. Nutrition, 35,
     93-99 . Link: 10.1016/j.nut.2016.10.012
142. Gabriela Achete de Souza, Sâmylla Vaz de Marqui, Júlia Novaes Matias, É. Guiguer, S. Barbalho (2020). Effects of Ginkgo biloba on Diseases Related to Oxidative Stress. Planta Medica, 86, 376 - 386. Link: 10.1055/a-1109-3405
143. J. Birks, J. Grimley Evans (2009). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 1,
     CD003120 . Link: 10.1002/14651858.CD003120.pub3
144. Grimley Evans, Van Dongen (2007). Ginkgo biloba for cognitive impairment and dementia.. The Cochrane database of systematic reviews, 2,
     CD003120 . Link: 10.1002/14651858.cd003120.pub2
145. S. Barbalho, R. Direito, LUCAS FORNARI LAURINDO, L. Marton, É. Guiguer, R. Goulart, R. J. Tofano, A. C. A. Carvalho, U. Flato, Viviane Alessandra Capelluppi Tofano, C. Detregiachi, P. C. S. Bueno, R. J. Girio, A. Araújo (2022). Ginkgo biloba in the Aging Process: A Narrative Review. Antioxidants, 11, . Link: 10.3390/antiox11030525
146. Farhad Eisvand, B. Razavi, H. Hosseinzadeh (2020). The effects of Ginkgo biloba on metabolic syndrome: A review.. Phytotherapy research : PTR, , . Link: 10.1002/ptr.6646
147. D. Barton, K. Burger, P. Novotny, T. Fitch, S. Kohli, G. Soori, M. Wilwerding, J. Sloan, L. Kottschade, K. Rowland, S. Dakhil, D. Nikcevich, C. Loprinzi (2013). The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Supportive Care in Cancer, 21, 1185-1192. Link: 10.1007/s00520-012-1647-9
148. D. Parsad, R. Pandhi, A. Juneja (2003). Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clinical and Experimental Dermatology, 28, . Link: 10.1046/j.1365-2230.2003.01207.x
149. N. Mulianto, Harijono Kariosentono, B. Purwanto, D. Indarto, S. Soetrisno, Ria Margiana (2022). Efficacy of adjuvant therapy gingko biloba extract on vitiligo treated by topical desoximetasone to melanin index and vasi score. International journal of health sciences, , . Link: 10.53730/ijhs.v6ns4.11935
150. J. Evans (2013). Ginkgo biloba extract for age-related macular degeneration.. The Cochrane database of systematic reviews, 1,
     CD001775 . Link: 10.1002/14651858.CD001775.pub2
151. B. Cohen, N. Elbuluk, E. Mu, S. Orlow (2015). Alternative Systemic Treatments for Vitiligo: A Review. American Journal of Clinical Dermatology, 16, 463-474. Link: 10.1007/s40257-015-0153-5
152. O. Szczurko, N. Shear, A. Taddio, H. Boon (2011). Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complementary and Alternative Medicine, 11, 21 - 21. Link: 10.1186/1472-6882-11-21
153. Shaolong Zhang, X. Yi, Xin Su, Z. Jian, Tingting Cui, Sen Guo, T. Gao, Chunying Li, Shuli Li, Qian Xiao (2019). Ginkgo biloba extract protects human melanocytes from H2O2‐induced oxidative stress by activating Nrf2. Journal of Cellular and Molecular Medicine, 23, 5193 - 5199. Link: 10.1111/jcmm.14393
154. Encarna Castillo, M. González-Rosende, I. Martínez-Solís (2022). The Use of Herbal Medicine in the Treatment of Vitiligo: An Updated Review. Planta Medica, 89, 468 - 483. Link: 10.1055/a-1855-1839
155. O. Szczurko, H. Boon (2008). A systematic review of natural health product treatment for vitiligo. BMC Dermatology, 8, 2 - 2. Link: 10.1186/1471-5945-8-2
156. A. Shakhbazova, Hera Wu, C. Chambers, R. Sivamani (2020). A Systematic Review of Nutrition, Supplement, and Herbal-Based Adjunctive Therapies for Vitiligo.. Journal of alternative and complementary medicine, , . Link: 10.1089/acm.2020.0292
157. H. Sahib, Ahmed R. Abu-raghif, N. Ali, I. Farhood, M. F. Hameed (2013). EVALUATION OF A STANDARDIZED EXTRACT OF GINKGO BILOBA IN VITILIGO REMEDY. Asian Journal of Pharmaceutical and Clinical Research, 6, 127-130. Link: